PTC Therapeutics
PTCT
#3095
Rank
NZ$9.34 B
Marketcap
NZ$111.83
Share price
-3.09%
Change (1 day)
-15.97%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: NZ$9.34 Billion

As of November 2026 PTC Therapeutics has a market cap of NZ$9.34 Billion. This makes PTC Therapeutics the world's 3095th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$9.34 B-14.21%
2025NZ$10.89 B76.08%
2024NZ$6.18 B88.08%
2023NZ$3.28 B-25.04%
2022NZ$4.38 B6.42%
2021NZ$4.12 B-28.57%
2020NZ$5.77 B30.67%
2019NZ$4.41 B70.59%
2018NZ$2.58 B165.72%
2017NZ$0.97 B80.28%
2016NZ$0.54 B-66.34%
2015NZ$1.60 B-26.14%
2014NZ$2.17 B342.21%
2013NZ$0.49 B

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of PTC Therapeutics was reported to be:

NZ$9.64 Billion
by Nasdaq info icon info icon
NZ$9.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$552.33 B 5,811.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$246.35 B 2,536.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$4.83 B-48.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.93 B-68.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.24 B-97.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$20.44 B 118.83%๐Ÿ‡บ๐Ÿ‡ธ USA